RSCM
YARW

Rock Springs Capital Management’s Yarrow Bioscience YARW Stock Holding History

Rock Springs Capital Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-92
Closed -$3.25M – 144
2018
Q3 		$3.25M Hold
92
– – 0.12% 130
2018
Q2 		$2.68M Hold
92
– – 0.1% 131
2018
Q1 		$12.4M Buy
+92
New +$11.2M 0.53% 67

Other funds holding YARW

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Rock Springs Capital Management's YARW Position: Q4 2018 in Review

Rock Springs Capital Management sold out of Yarrow Bioscience (YARW) in Q4 2018, closing a stake of 92 shares — an estimated $3.25M sold.

Rock Springs Capital Management first reported a position in YARW in Q1 2018 and held it in 3 quarters. The position peaked at $12.4M in Q1 2018. 45 funds tracked by Wall St. Rank hold YARW as of Q4 2018.

  • Rock Springs Capital Management reported no remaining Yarrow Bioscience position as of Q4 2018 after selling out during the quarter.
  • Rock Springs Capital Management sold 92 Yarrow Bioscience shares in Q4 2018, an estimated $3.25M.
  • Rock Springs Capital Management first reported a position in Yarrow Bioscience in Q1 2018 and held it in 3 quarters.
  • Rock Springs Capital Management's Yarrow Bioscience position peaked at $12.4M in Q1 2018.
  • 45 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q4 2018.

Based on Rock Springs Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.